107 related articles for article (PubMed ID: 22264880)
1. Preclinical pharmacokinetic analysis of felotaxel (SHR110008), a novel derivative of docetaxel, in rats and its protein binding ability in vitro.
Ding Y; Liu W; Lu C; Yang J; Zhu Y; Song Y; Ma Z; Yang L; Jia Y; Wen A
Biomed Pharmacother; 2012 Mar; 66(2):98-102. PubMed ID: 22264880
[TBL] [Abstract][Full Text] [Related]
2. Application of a liquid chromatography-tandem mass spectrometry (LC-MS/MS) method to the pharmacokinetics, tissue distribution and excretion studies of felotaxel (SHR110008) in tumor-bearing mice.
Ding Y; Lu C; Yang J; Jin X; Yang L; Wang C; Ma Z; Zhu Y; Ding L; Jia Y; Wen A
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Mar; 887-888():61-6. PubMed ID: 22309773
[TBL] [Abstract][Full Text] [Related]
3. High-performance liquid chromatographic analysis of felotaxel, a novel anti-cancer drug, in rat plasma and in human plasma and urine.
Yan L; YanYan J; MinChun C; Jing Y; Ying S; ChengTao L; Jie G; CaiYang L; ZhenXing Z; AiDong W; Yi D
J Chromatogr Sci; 2013 Mar; 51(3):292-6. PubMed ID: 22933511
[TBL] [Abstract][Full Text] [Related]
4. Preclinical pharmacokinetics and in vitro activity of ON 01910.Na, a novel anti-cancer agent.
Chun AW; Cosenza SC; Taft DR; Maniar M
Cancer Chemother Pharmacol; 2009 Dec; 65(1):177-86. PubMed ID: 19466411
[TBL] [Abstract][Full Text] [Related]
5. Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.
Matsumoto S; Tagawa M; Amejima H; Nakao M; Kagemoto A; Fujii T; Miyazaki H; Sekine Y
Arzneimittelforschung; 1993 Oct; 43(10):1084-94. PubMed ID: 8267675
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic characterization of a natural product-inspired novel MEK1 inhibitor E6201 in preclinical species.
Kumar V; Schuck EL; Pelletier RD; Farah N; Condon KB; Ye M; Rowbottom C; King BM; Zhang ZY; Saxton PL; Wong YN
Cancer Chemother Pharmacol; 2012 Jan; 69(1):229-37. PubMed ID: 21698359
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics, tissue distribution and excretion study of dl-praeruptorin A of Peucedanum praeruptorum in rats by liquid chromatography tandem mass spectrometry.
Zhang Z; Liu YY; Su MQ; Liang XF; Wang WF; Zhu X
Phytomedicine; 2011 Apr; 18(6):527-32. PubMed ID: 21036581
[TBL] [Abstract][Full Text] [Related]
8. Plasma pharmacokinetics and tissue distribution study of cajaninstilbene acid in rats by liquid chromatography with tandem mass spectrometry.
Hua X; Fu YJ; Zu YG; Wu N; Kong Y; Li J; Peng X; Efferth T
J Pharm Biomed Anal; 2010 Jun; 52(2):273-9. PubMed ID: 20116956
[TBL] [Abstract][Full Text] [Related]
9. Single-dose pharmacokinetics of Nestorone, a potential female-contraceptive.
Prasad PV; Bashir M; Sitruk-Ware R; Kumar N
Steroids; 2010 Mar; 75(3):252-64. PubMed ID: 20064539
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and distribution of SN 28049, a novel DNA binding anticancer agent, in mice.
Lukka PB; Paxton JW; Kestell P; Baguley BC
Cancer Chemother Pharmacol; 2010 May; 65(6):1145-52. PubMed ID: 19774378
[TBL] [Abstract][Full Text] [Related]
11. Absorption, protein binding, pharmacokinetics and excretion of the anti-ischemic and anti-hypertensive arylpiperazine derivative CDRI-93/478 in rats.
Lal J; Gupta RC
Arzneimittelforschung; 2008; 58(2):62-70. PubMed ID: 18412019
[TBL] [Abstract][Full Text] [Related]
12. Preclinical pharmacology of the natural product anticancer agent bryostatin 1, an activator of protein kinase C.
Zhang X; Zhang R; Zhao H; Cai H; Gush KA; Kerr RG; Pettit GR; Kraft AS
Cancer Res; 1996 Feb; 56(4):802-8. PubMed ID: 8631017
[TBL] [Abstract][Full Text] [Related]
13. Investigation on pharmacokinetics, tissue distribution and excretion of a novel anticancer platinum compound by inductively coupled plasma mass spectrometry after intravenous administration to rats.
Liu QF; Li X; Su Q; Luo GA; Wang YM; Liu WP
Arch Pharm Res; 2009 Nov; 32(11):1621-8. PubMed ID: 20091277
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and tissue distribution of docetaxel by liquid chromatography-mass spectrometry: evaluation of folate receptor-targeting amphiphilic copolymer modified nanostructured lipid carrier.
Zhao X; Zhao Y; Geng L; Li X; Wang X; Liu Z; Wang D; Bi K; Chen X
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Dec; 879(31):3721-7. PubMed ID: 22035980
[TBL] [Abstract][Full Text] [Related]
15. Plasma and cerebrospinal fluid pharmacokinetics of the novel tetrahydroisoquinoline EDL-155 in rats.
Song P; Ma F; Wang F; Wang X; Patil R; Ramagiri S; Orr WE; Miller DD; Geisert E; Yates CR
Cancer Chemother Pharmacol; 2008 May; 61(6):1037-44. PubMed ID: 17768626
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and tissue and tumor exposure of CP-31398, a p53-stabilizing agent, in rats.
Kapetanovic IM; Muzzio M; McCormick DL; Thompson TN; Johnson WD; Horn TL; Mohammed A; Rao CV; Kopelovich L
Cancer Chemother Pharmacol; 2012 May; 69(5):1301-6. PubMed ID: 22302406
[TBL] [Abstract][Full Text] [Related]
17. Investigation on pharmacokinetics, tissue distribution and excretion of a novel platinum anticancer agent in rats by inductively coupled plasma mass spectrometry (ICP-MS).
Zhao J; Wen Y; Zhang W; Zhao D; Fan A; Zhang Y; Deng S; Wang X; Liu Q; Lu Y; Wang Z; Gou S; Chen X
Xenobiotica; 2014 Aug; 44(8):757-62. PubMed ID: 24524624
[TBL] [Abstract][Full Text] [Related]
18. Dosing sequence-dependent pharmacokinetic interaction of oxaliplatin with paclitaxel in the rat.
Liu J; Kraut EH; Balcerzak S; Grever M; D'Ambrosio S; Chan KK
Cancer Chemother Pharmacol; 2002 Dec; 50(6):445-53. PubMed ID: 12451470
[TBL] [Abstract][Full Text] [Related]
19. Application of an LC-MS/MS method to the pharmacokinetics of TM-2, a potential antitumour agent, in rats.
Men L; Zhao Y; Lin H; Yang M; Liu H; Shao Y; Fan R; Tang X; Yu Z
Drug Test Anal; 2015 Jun; 7(6):544-9. PubMed ID: 25209951
[TBL] [Abstract][Full Text] [Related]
20. Disposition of the novel anticancer agent vinorelbine ditartrate following intravenous administration in mice, rats and dogs.
Kobayashi S; Sakai T; Dalrymple PD; Wood SG; Chasseaud LF
Arzneimittelforschung; 1993 Dec; 43(12):1367-77. PubMed ID: 8141830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]